Lobbying

Healthcare Association of NYS's latest lobbying report covers Q2 2026, at $110K. The four quarters Q4 2025–Q3 2026 total $330K. Its first report covers Q2 2021; the issues it reports most are Medicare/Medicaid.

Healthcare Association of NYS

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$330K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q2 2021
The first quarter a report named it

Lobbying by quarter

Healthcare Association of NYS lobbying by quarter
Healthcare Association of NYS lobbying by quarter
QuarterAmountReports
Q2 2021$130K1
Q3 2021$00
Q4 2021$00
Q1 2022$00
Q2 2022$00
Q3 2022$00
Q4 2022$150K1
Q1 2023$170K1
Q2 2023$140K1
Q3 2023$110K1
Q4 2023$120K1
Q1 2024$110K1
Q2 2024$110K1
Q3 2024$90K1
Q4 2024$100K1
Q1 2025$140K1
Q2 2025$150K1
Q3 2025$100K1
Q4 2025$100K1
Q1 2026$120K1
Q2 2026$110K1
Q3 2026$00

By issue

  • Medicare and Medicaid$2M · 16 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health & Human Services, Dept of (HHS)16 reports
  • HOUSE OF REPRESENTATIVES16 reports
  • SENATE16 reports
  • Federal Emergency Management Agency (FEMA)11 reports
  • Health Resources & Services Administration (HRSA)2 reports
  • Homeland Security, Dept of (DHS)2 reports
  • Centers For Medicare and Medicaid Services (CMS)1 reports

Firms it paid

Firm
In-houseHealthcare Association of NYS$2M16 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/17for Q2In-house$110K
04/20for Q1In-house$120K
01/21for Q4 2025In-house$100K
25/10/20for Q3 2025In-house$100K
25/07/21for Q2 2025In-house$150K
25/04/21for Q1 2025In-house$140K
25/01/21for Q4 2024In-house$100K
24/10/21for Q3 2024In-house$90K
24/09/13for Q2 2024In-house$110K
24/09/13for Q1 2024In-house$110K
24/07/24for Q1 2024In-house$110K
24/07/22for Q2 2024In-house$110K
24/04/22for Q2 2021In-house$130K
24/04/22for Q4 2023In-house$120K
24/04/22for Q1 2024In-house$100K
24/01/29for Q4 2023In-house$110K
24/01/29for Q4 2023In-house$110K
24/01/19for Q4 2023In-house$110K
23/12/14for Q3 2023In-house$110K
23/10/19for Q3 2023In-house$100K